🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Renaissance Technologies (RenTech)’s EIKN Holdings & Trades

First Buy
Q2 2026
Duration Held
1 Quarters
Largest Add
Q2 2026
+26,797 Shares
Current Position
26,797 Shares
$349,701 Value

Renaissance Technologies (RenTech)'s EIKN Position Overview

Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 26,797 shares of Eikon Therapeutics, Inc. (EIKN) worth $349,701, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.

Based on recent 13F filings, Renaissance Technologies (RenTech) has initiated a new position in EIKN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

Renaissance Technologies (RenTech)'s Eikon Therapeutics (EIKN) Holding Value Over Time

Track share changes against reported price movement

Quarterly Eikon Therapeutics (EIKN) Trades by Renaissance Technologies (RenTech)

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +26,797 New Buy 26,797 $13.05

Renaissance Technologies (RenTech)'s Eikon Therapeutics Investment FAQs

Renaissance Technologies (RenTech) first purchased Eikon Therapeutics, Inc. (EIKN) in Q2 2026, acquiring 26,797 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Renaissance Technologies (RenTech) has held Eikon Therapeutics, Inc. (EIKN) for 1 quarters since Q2 2026.

Renaissance Technologies (RenTech)'s largest addition to Eikon Therapeutics, Inc. (EIKN) was in Q2 2026, adding 26,797 shares worth $349,701.

According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 26,797 shares of Eikon Therapeutics, Inc. (EIKN), valued at approximately $349,701.

As of the Q2 2026 filing, Eikon Therapeutics, Inc. (EIKN) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.

Renaissance Technologies (RenTech)'s peak holding in Eikon Therapeutics, Inc. (EIKN) was 26,797 shares, as reported at the end of Q2 2026.